Kodiak Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-260.49	-333.82	-266.99	-133.1	-47.37	-41.44	-27.94	-17.13
Depreciation & Amortization	25.95	11	8.71	4.21	0.91	0.49	0.55	0.26
Share-Based Compensation	88.56	106.03	61.39	30.67	6.11	2.67	0.28	0.27
Other Operating Activities	-8.2	10.33	14.62	14.79	1.2	9.26	9.46	0.56
Operating Cash Flow	-154.18	-206.46	-182.27	-83.43	-39.15	-29.03	-17.66	-16.05
Capital Expenditures	-41.43	-47.36	-63.3	-7	-0.44	-0.58	-0.21	-0.77
Change in Investments	290.65	-289.77	24.5	111.83	-136.56	0	0	0
Other Investing Activities	-	0.62	-	-	-	-	-	-
Investing Cash Flow	249.23	-336.51	-38.8	104.83	-137	-0.58	-0.21	-0.77
Share Issuance / Repurchase	0.24	1.94	8.23	617.78	299.77	83.8	0	0
Debt Issued / Paid	0	0	0	-0.01	-0.05	32.75	9.72	-0.06
Other Financing Activities	-0.21	-0.05	-0.05	99.61	-0.04	-0.09	-0.09	-0.06
Financing Cash Flow	0.03	1.9	8.18	717.38	299.69	116.47	9.64	-0.12
Net Cash Flow	95.07	-541.08	-212.89	738.78	123.54	86.86	-8.23	-16.94
Free Cash Flow	-195.61	-253.82	-245.57	-90.43	-39.58	-29.61	-17.86	-16.82
Free Cash Flow Per Share	-3.73	-4.86	-4.74	-1.98	-1.05	-1.98	-2.38	-2.33

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).